Al-Sawaf O. High-risk stays high-risk: Bruton tyrosine kinase inhibitors in B-cell malignancies. haematol [Internet]. 2024Jul.1 [cited 2024Jul.3];109(7):2035-7. Available from: https://haematologica.org/article/view/haematol.2024.285029